Health Trials

Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

1

Review clinical trials related to Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Participants needed: 177
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: NS Pharma, Inc.Updated: Feb 27, 2026
Eligibility criteria

Ability to provide written informed consent prior to participation in the trial,... [+9]

Have a diagnosis of PAH or PH for reasons other than WHO Group 3 PH-ILD as outli... [+26]

Read more